STOCK TITAN

LifeStance Health (LFST) Form 144 shows planned sale of 1.09M shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LifeStance Health Group Inc. has filed a notice for a proposed resale of its common stock. The filing indicates a planned sale of 1,088,162 shares, with an aggregate market value of $11,556,280.44, to be sold on or after 08/10/2026 on NASDAQ through Citadel Securities LLC. The seller previously purchased 18,446,106 equity interests in LifeStance in a pre-IPO transaction on 06/10/2021.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 1,088,162 shares Common stock covered by the Form 144 notice
Aggregate market value of shares $11,556,280.44 Value associated with the 1,088,162 shares of common stock
Equity interests purchased pre-IPO 18,446,106 units Equity interests in LifeStance acquired on 06/10/2021 pre-IPO
Planned sale date 08/10/2026 Date from which the proposed NASDAQ sales may begin
Securities To Be Sold regulatory
"144: Securities To Be Sold Common Stock | 06/10/2021 | Pre-IPO Transactions"
pre-IPO financial
"Pre-IPO Transactions | LifeStance Health Group Inc. | | | 18446106"
Pre-IPO describes the stage when a privately held company offers shares or commitments to investors before its initial public offering. For investors, pre-IPO deals can provide a chance to buy equity at lower prices—like getting into a house before it goes on the market—but they come with higher uncertainty, limited ability to sell quickly, and the risk that the public listing may be delayed, changed, or never occur.
Equity interests financial
"Equity interests in the Issuer were purchased pre-IPO."
Equity interests are an ownership stake in a company—usually represented by shares or membership units—that give the holder a claim on the business’s profits, assets and sometimes voting power. Think of it as owning one or more slices of a company’s pie: the bigger your slice, the larger your share of dividends, capital gains and influence, and the more you are affected by dilution or company losses. Investors use equity interests to measure value, control and potential returns.
Common Stock financial
"Common Stock | Citadel Securities LLC 830 Brickell Plaza"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does LifeStance Health Group Inc. (LFST) disclose in this Form 144?

The filing discloses a planned resale of 1,088,162 shares of LifeStance common stock. The shares have an aggregate market value of $11,556,280.44 and are expected to be sold on or after 08/10/2026 on NASDAQ.

How many LifeStance Health (LFST) shares are planned to be sold and at what value?

The Form 144 covers a proposed sale of 1,088,162 shares of LifeStance common stock. The filing lists an aggregate market value of approximately $11,556,280.44 for these shares, reflecting the market price at the time of the notice.

When is the proposed sale date for the LifeStance (LFST) shares in this Form 144?

The planned sale is indicated for 08/10/2026. This date marks when the selling holder expects to begin resales of LifeStance common stock on NASDAQ through Citadel Securities LLC, subject to applicable Rule 144 conditions.

Who is the broker for the planned LifeStance Health (LFST) share sale?

The Form 144 lists Citadel Securities LLC as the broker for the transaction. The planned sale of 1,088,162 LifeStance common shares is expected to occur on NASDAQ through this broker starting on or after 08/10/2026.

What pre-IPO transaction does the LifeStance (LFST) Form 144 reference?

The filing notes that 18,446,106 equity interests in LifeStance Health Group Inc. were purchased in a pre-IPO transaction on 06/10/2021. This provides background on how the seller originally acquired the securities now proposed for resale.

Is LifeStance Health (LFST) issuing new shares in this Form 144 filing?

No, the disclosure relates to a resale of existing common stock under Rule 144. The filing describes a holder’s plan to sell 1,088,162 shares it already owns, rather than LifeStance issuing new shares for capital raising.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature